J&J Revenue Up on Surge in Heart Procedures
Wall Street Journal
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share.
https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2